217 related articles for article (PubMed ID: 33616081)
1. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans.
Miyata T; Wu X; Fan X; Huang E; Sanz-Garcia C; Ross CKC; Roychowdhury S; Bellar A; McMullen MR; Dasarathy J; Allende DS; Caballeria J; Sancho-Bru P; McClain CJ; Mitchell M; McCullough AJ; Radaeva S; Barton B; Szabo G; Dasarathy S; Nagy LE
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33616081
[TBL] [Abstract][Full Text] [Related]
2. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
[TBL] [Abstract][Full Text] [Related]
3. Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice.
Wu X; Arya RK; Huang E; McMullen MR; Nagy LE
Front Endocrinol (Lausanne); 2023; 14():1267996. PubMed ID: 38161978
[TBL] [Abstract][Full Text] [Related]
4. The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.
Chen H; McKeen T; Chao X; Chen A; Deng F; Jaeschke H; Ding WX; Ni HM
Int J Biol Sci; 2022; 18(3):1096-1106. PubMed ID: 35173541
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis.
Wu X; Fan X; McMullen MR; Miyata T; Kim A; Pathak V; Wu J; Day LZ; Hardesty JE; Welch N; Dasarathy J; Allende DS; McCullough AJ; Jacobs JM; Rotroff DM; Dasarathy S; Nagy LE
Hepatology; 2023 Mar; 77(3):902-919. PubMed ID: 35689613
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
7. Phosphoproteomics identifies pathways underlying the role of receptor-interaction protein kinase 3 in alcohol-associated liver disease and uncovers apoptosis signal-regulating kinase 1 as a target.
Singh V; Huang E; Pathak V; Willard BB; Allende DS; Nagy LE
Hepatol Commun; 2022 Aug; 6(8):2022-2041. PubMed ID: 35438255
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
9. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
Shrestha A; Mehdizadeh Gohari I; McClane BA
mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
[No Abstract] [Full Text] [Related]
10. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.
Chen W; Zhou Z; Li L; Zhong CQ; Zheng X; Wu X; Zhang Y; Ma H; Huang D; Li W; Xia Z; Han J
J Biol Chem; 2013 Jun; 288(23):16247-16261. PubMed ID: 23612963
[TBL] [Abstract][Full Text] [Related]
11. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.
Wang S; Ni HM; Dorko K; Kumer SC; Schmitt TM; Nawabi A; Komatsu M; Huang H; Ding WX
Oncotarget; 2016 Apr; 7(14):17681-98. PubMed ID: 26769846
[TBL] [Abstract][Full Text] [Related]
13. Palmitate induces RIP1/RIP3-dependent necrosis via MLKL-mediated pore formation in the plasma membrane of RAW 264.7 cells.
Kim SK; Yun M; Seo G; Lee JY; Lee SB
Biochem Biophys Res Commun; 2017 Jan; 482(2):359-365. PubMed ID: 27856241
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3)-Mixed Lineage Kinase Domain-Like Protein (MLKL)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers.
Ni HM; Chao X; Kaseff J; Deng F; Wang S; Shi YH; Li T; Ding WX; Jaeschke H
Am J Pathol; 2019 Jul; 189(7):1363-1374. PubMed ID: 31026418
[TBL] [Abstract][Full Text] [Related]
15. Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.
Ohene-Marfo P; Nguyen HVM; Mohammed S; Thadathil N; Tran A; Nicklas EH; Wang D; Selvarani R; Farriester JW; Varshney R; Kinter M; Richardson A; Rudolph MC; Deepa SS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474061
[TBL] [Abstract][Full Text] [Related]
16. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.
Wang H; Sun L; Su L; Rizo J; Liu L; Wang LF; Wang FS; Wang X
Mol Cell; 2014 Apr; 54(1):133-146. PubMed ID: 24703947
[TBL] [Abstract][Full Text] [Related]
17. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
Im KH; Saeed WK; Kim EB; Lee AH; Kim JE; Lee SM; Hanning X; Kim HS; Jun DW; Yoon EL
Dig Dis Sci; 2024 May; 69(5):1701-1713. PubMed ID: 38551744
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts.
Ino S; Yano T; Kuno A; Tanno M; Kouzu H; Sato T; Yamashita T; Ohwada W; Osanami A; Ogawa T; Toda Y; Shimizu M; Miura T
J Pharmacol Sci; 2023 Feb; 151(2):134-143. PubMed ID: 36707179
[TBL] [Abstract][Full Text] [Related]
20. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
